Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aging
New aging study findings recently were published by researchers at University of Milan
January 18th, 2009
"Vascular endothelial growth factor (VEGF) gene polymorphisms have been associated with an increased risk of developing a wide variety of disorders from diabetes to neurodegenerative diseases suggesting functions not confined to its vascular effects originally described. Based on the VEGF protective roles undisclosed in pathological conditions', we evaluate whether VEGF variability might be a determinant also for longevity," scientists in Milan, Italy report. "Four polymorphisms (-2578C/A, -1190G/A, -1154G/A and -634G/C) within the VEGF gene promoter region it] 490 unrelated Italian healthy subjects have been analysed. Significant changes of allele, genotype (-2578/AA...
Source: Pharma Investments, Ventures & Law Weekly (2009-01-18)
|
